Page 126 - 2020年1月第31卷第2期

sealed erythrocytes：an engineering approach for drug de- blood cells：supercarriers for drugs，biologicals，and
livery and drug targeting[J]. J Chem Pharma Res，2016，8 nanoparticles and inspiration for advanced delivery sys-
（5）：376-384. tems[J]. Adv Drug Deliv Rev，2016，106（11）：88-103.
[34] ALVAREZFIGUEROA MJ，BLANCOMACNDEZ J. [48] SUYAMA K，KAWASAKI Y，MIYAZAKI K，et al. The
Transdermal delivery of methotrexate：iontophoretic de- efficacy of recombinant human soluble thrombomodulin
livery from hydrogels and passive delivery from microe- for the treatment of shiga toxin-associated hemolytic ure-
mulsions[J]. Int J Pharm，2001，215（1）：57-65. mic syndrome model mice[J]. Nephrol Dial Transpl，
[35] HARISA G，IBRAHIM MF，ALANAZI FK. Characteriza- 2015，30（6）：969-977.
tion of human erythrocytes as potential carrier for pravas- [49] TANEMURAA，KURIYAMA N，AZUMI Y，et al. Throm-
tatin：an in vitro study[J]. Int J Med Sci，2011，8（3）：222- bomodulin administration attenuates ischemia-reperfusion
230. injury of the remnant liver after 70％hepatectomy in rats：
[36] BALASUBRAMANIAN J，NARAYANAN N，KUMAR simulated model of small-for-size graft in living donor li-
V. Resealed erythrocytes：a novel drug carrier in drug de- ver transplantation[J]. Transpl P，2014，46（4）：1107-
livery[J]. Drug Discov，2012，2（6）：30-32. 1111.
[37] HAMIDI M，TAJERZADEH H，DEHPOUR AR，et al. In [50] IKEZOE T，YANG J，NISHIOKA C，et al. Thrombomodu-
vitro characterization of human intact erythrocytes loaded lin alleviates murine GVHD in association with an in-
by enalaprilat[J]. J Toxicol Sci，2001，8（4）：223-230. crease in the proportion of regulatory T cells in the
[38] LI LH，HENSEN ML，ZHAO YL，et al. Electrofusion be- spleen[J]. Bone Marrow Transpl，2015，50（1）：113-120.
tween heterogeneous-sized mammalian cells in a pellet： [51] 吴江，钱宝华.长春新碱载体红细胞制备及性能的实验研
potential applications in drug delivery and hybridoma for- 究[D].上海：第二军医大学，2004.
mation[J]. Biophys J，1996，71（1）：479-486. [52] 霍晶.甲氨蝶呤红细胞载体的制备及在大鼠体内药代动
[39] JAIN T，ADHAV R，VASWANI P. Erythrocytes as drug 力学研究[D].南京：南京中医药大学，2008.
delivery system：a boon to cure[J]. Int Res J Pure Appl [53] BERNHARDT I，ELLORY JC. Red cell membrane trans-
Chem，2015，1（1）：21-26. port in health and disease[M]. Second Edition. Berlin：
[40] NICOLAU C，GERSONDE K. Incorporation of inositol Springer Science & Business Media，2013：373-405.
hexaphosphate into intact red blood cells[J]. Naturwissen- [54] WIBROE PP，ANSELMO AC，NILSSON PH，et al.By-
schaften，1979，66（11）：563-566. passing adverse injection reactions to nanoparticles
[41] JAITELY V，KANAUJIA P，VENKATESAN N，et al. Re- through shape modification and attachment to erythro-
sealed erythrocytes：drug carrier potentials and biomedical cytes[J]. Nature Nanotechnol，2017，12（6）：589-594.
applications[J]. Indian Drugs，1996，33（12）：589-594. [55] 张越，杨阳，翟美芳. T7肽修饰的载长春新碱低密度脂蛋
[42] MAGNANI M，ROSSI L，D’ASCENZO M，et al. Erythro- 白纳米粒的制备及脑胶质瘤靶向性和治疗作用评价[J].
cyte engineering for drug delivery and targeting[J]. Bio- 药学学报，2018，53（3）：460-466.
thchnol Appl Bioc，1998，28（1）：1-6. [56] YUAN SH，GE WH，HUO J，et al. Slow release properties
[43] SKOROKHOD OA，VITVITSKY VM，ISAEV VG，et al. and liver-targeting characteristics of methotrexate erythro-
Pharmacokinetics of erythrocyte-bound daunorubicin in cyte carriers.[J]. Fund Clin Pharmacol，2009，23（2）：
patients with acute leukemia[J]. Med Sci Monitor，2004， 189-196.
10（4）：155-164. [57] 任伟.融合蛋白ANTI-EGFR-IRGD修饰的负载紫杉醇的
[44] MUZYKANTOV VR，CHRISTOFIDOU-SOLOMIDOU 红细胞膜纳米粒子的构建及其对食管癌的放疗增敏作
M，BALYASNIKOVA I，et al. Streptavidin facilitates inter- 用与机制[D].南京：南京医科大学，2018.
nalization and pulmonary targeting of an anti-endothelial [58] ZARRIN A，FOROOZESH M，HAMIDI M. Carrier eryth-
cell antibody（platelet-endothelial cell adhesion molecule rocytes：recent advances，present status，current trends and
1）：a strategy for vascular immunotargeting of drugs[J]. future horizons[J]. Expert Opin Drug Del，2014，11（3）：
Proc Natl Acad Sci USA，1999，96（5）：2379-2384. 433-447.
[45] MÜLLER M，BUCHI L，WOODTLI K，et al. Preparation [59] MILLáN CG，CASTAÑEDA AZ，LÓPEZ F G，et al. En-
and characterization of“heparinocytes”：erythrocytes with capsulation and in vitro evaluation of amikacin-loaded
covalently bound low molecular weight heparin[J]. FEBS erythrocytes[J]. Drug Deliv，2005，12（6）：409-416.
Letters，2000，468（2）：115-119. [60] 骆璇，汪小海，徐鑫，等.冠脉搭桥术病人红细胞包蔽吗啡
[46] BRENNER JS，PAN DC，MYERSON JW，et al. Red 溶液术后镇痛的可行性[J].中华麻醉学杂志，2005，25
blood cell-hitchhiking boosts delivery of nanocarriers to （6）：410-413.
chosen organs by orders of magnitude[J]. Nature Com- [61] ALANAZI FK，GELD H，MAQBOUL A，et al. Biochemi-
mun，2018，9（1）：1-14. cally altered human erythrocytes as a carrier for targeted
[47] VILLA CH，ANSELMO AC，MITRAGOTRI S，et al. Red delivery of primaquine：an in vitro study[J]. Arch Pharm

·244 · China Pharmacy 2020 Vol. 31 No. 2 中国药房 2020年第31卷第2期